Van-den Berghe's 5q- syndrome in 2008

British Journal of Haematology

Volumn 144, Issue 2, 2009, Pages 157-168

  Mohamedali, Azim ^a   Mufti, Ghulam J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

5q syndrome; Lenalidomide; Myelodysplastic syndrome; RPS14

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; LENALIDOMIDE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; RIBOSOME PROTEIN; RIBOSOME PROTEIN S14; THALIDOMIDE; UNCLASSIFIED DRUG;

5Q- SYNDROME; BONE MARROW DEPRESSION; BONE MARROW SUPPRESSION; CHROMOSOME 5Q; CHROMOSOME DELETION; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG MECHANISM; GENE DELETION; HUMAN; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; REVIEW; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 5; CYTOGENETICS; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; MYELODYSPLASTIC SYNDROMES; RIBOSOMAL PROTEINS; THALIDOMIDE;

EID: 58149093239     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07447.x     Document Type: Review

References (99)

1. Alter, B.P. (2007) Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology (American Society of Hematology Education Program), 2007, 29 39.
2. Amsterdam, A., Sadler, K.C., Lai, K., Farrington, S., Bronson, R.T., Lees, J.A. Hopkins, N. (2004) Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biology, 2, E139.
3. Baron, V., Adamson, E.D., Calogero, A., Ragona, G. Mercola, D. (2006) The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Therapy, 13, 115 124.
4. Bartlett, J.B., Dredge, K. Dalgleish, A.G. (2004) The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nature Reviews. Cancer, 4, 314 322.
5. Bernasconi, P., Klersy, C., Boni, M., Cavigliano, P.M., Calatroni, S., Giardini, I., Rocca, B., Zappatore, R., Caresana, M., Quarna, J., Lazzarino, M. Bernasconi, C. (2005) Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution. Leukemia, 19, 1424 1431.
6. Boultwood, J., Fidler, C., Lewis, S., Kelly, S., Sheridan, H., Littlewood, T.J., Buckle, V.J. Wainscoat, J.S. (1994) Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint. Genomics, 19, 425 432.
7. Boultwood, J., Fidler, C., Strickson, A.J., Watkins, F., Gama, S., Kearney, L., Tosi, S., Kasprzyk, A., Cheng, J.F., Jaju, R.J. Wainscoat, J.S. (2002) Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood, 99, 4638 4641.
8. Boultwood, J., Pellagatti, A., Cattan, H., Lawrie, C.H., Giagounidis, A., Malcovati, L., Della Porta, M.G., Jadersten, M., Killick, S., Fidler, C., Cazzola, M., Hellstrom-Lindberg, E. Wainscoat, J.S. (2007) Gene expression profiling of CD34+ cells in patients with the 5q- syndrome. British Journal Haematology, 139, 578 589.
9. Bowen, D., Culligan, D., Jowitt, S., Kelsey, S., Mufti, G., Oscier, D. Parker, J. (2003) Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. British Journal Haematology, 120, 187 200.
10. Calkhoven, C.F., Muller, C., Martin, R., Krosl, G., Pietsch, H., Hoang, T. Leutz, A. (2003) Translational control of SCL-isoform expression in hematopoietic lineage choice. Genes and Development, 17, 959 964.
11. Calligaris, R., Bottardi, S., Cogoi, S., Apezteguia, I. Santoro, C. (1995) Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proceedings of the National Academy of Sciences of the United States of America, 92, 11598 11602.
12. Cao, X.M., Koski, R.A., Gashler, A., McKiernan, M., Morris, C.F., Gaffney, R., Hay, R.V. Sukhatme, V.P. (1990) Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Molecular and Cellular Biology, 10, 1931 1939.
13. Chen, T.H., Walshauser, M., Kambal, A., Raju, G. Walter, M.J. (2007) Reduced HSPA9B expression, a 5q31.2 candidate gene, in primary human CD34+ cells recapitulates features of ineffective hematopoiesis observed in MDS. Blood (ASH Annual Meeting Abstracts), 110, 116.
14. Corral, L.G., Haslett, P.A., Muller, G.W., Chen, R., Wong, L.M., Ocampo, C.J., Patterson, R.T., Stirling, D.I. Kaplan, G. (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. Journal of Immunology, 163, 380 386.
15. Craven, S.E., French, D., Ye, W., de Sauvage, F. Rosenthal, A. (2005) Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome. Blood, 105, 3528 3534.
16. Dana, S.L., Chang, S. Wasmuth, J.J. (1985) Synthesis and incorporation of human ribosomal protein S14 into functional ribosomes in human-Chinese hamster cell hybrids containing human chromosome 5: human RPS14 gene is the structural gene for ribosomal protein S14. Somatic Cell and Molecular Genetics, 11, 625 631.
17. Davies, F.E., Raje, N., Hideshima, T., Lentzsch, S., Young, G., Tai, Y.T., Lin, B., Podar, K., Gupta, D., Chauhan, D., Treon, S.P., Richardson, P.G., Schlossman, R.L., Morgan, G.J., Muller, G.W., Stirling, D.I. Anderson, K.C. (2001) Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood, 98, 210 216.
18. Dredge, K., Horsfall, R., Robinson, S.P., Zhang, L.H., Lu, L., Tang, Y., Shirley, M.A., Muller, G., Schafer, P., Stirling, D., Dalgleish, A.G. Bartlett, J.B. (2005) Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro. Microvascular Research, 69, 56 63.
19. Dror, Y. Freedman, M.H. (2001) Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. Blood, 97, 3011 3016.
20. Ebert, B.L., Pretz, J., Bosco, J., Chang, C.Y., Tamayo, P., Galili, N., Raza, A., Root, D.E., Attar, E., Ellis, S.R. Golub, T.R. (2008) Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature, 451, 335 339.
21. Echard, A., Jollivet, F., Martinez, O., Lacapere, J.J., Rousselet, A., Janoueix-Lerosey, I. Goud, B. (1998) Interaction of a Golgi-associated kinesin-like protein with Rab6. Science, 279, 580 585.
22. Fewell, S.W. Woolford, Jr., J.L. (1999) Ribosomal protein S14 of Saccharomyces cerevisiae regulates its expression by binding to RPS14B pre-mRNA and to 18S rRNA. Molecular and Cellular Biology, 19, 826 834.
23. Flotow, H. Thomas, G. (1992) Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver. Journal of Biological Chemistry, 267, 3074 3078.
24. Flygare, J., Kiefer, T., Miyake, K., Utsugisawa, T., Hamaguchi, I., Da Costa, L., Richter, J., Davey, E.J., Matsson, H., Dahl, N., Wiznerowicz, M., Trono, D. Karlsson, S. (2005) Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia. Blood, 105, 4627 4634.
25. Flygare, J., Aspesi, A., Bailey, J.C., Miyake, K., Caffrey, J.M., Karlsson, S. Ellis, S.R. (2007) Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood, 109, 980 986.
26. Fontijn, R.D., Goud, B., Echard, A., Jollivet, F., van Marle, J., Pannekoek, H. Horrevoets, A.J. (2001) The human kinesin-like protein RB6K is under tight cell cycle control and is essential for cytokinesis. Molecular and Cellular Biology, 21, 2944 2955.
27. Gandhi, A.K., Kang, J., Naziruddin, S., Parton, A., Schafer, P.H. Stirling, D.I. (2006) lenalidomide inhibits proliferation of Namalwa CSN.70 cells and interferes with Gab1 phosphorylation and adaptor protein complex assembly. Leukemia Research, 30, 849 858.
28. Gandhi, A.K., Kang, J., Verhelle, D., Stirling, D.I. Schafer, P.H. (2007) Inhibition of cell proliferation by lenalidomide is associated with stimulation of Egr1 transcriptional activity in a chromosome 5 deleted Burkitt's lymphoma and multiple myeloma cell line. Journal of Clinical Oncology (Meeting Abstracts), 25, 8110.
29. Gazda, H.T., Kho, A.T., Sanoudou, D., Zaucha, J.M., Kohane, I.S., Sieff, C.A. Beggs, A.H. (2006) Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells, 24, 2034 2044.
30. Giagounidis, A.A., Germing, U., Haase, S., Hildebrandt, B., Schlegelberger, B., Schoch, C., Wilkens, L., Heinsch, M., Willems, H., Aivado, M. Aul, C. (2004) Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31. Leukemia, 18, 113 119.
31. Gondek, L.P., Dunbar, A., O'Keefe, C., McDevitt, M.A., Batista, D., Theil, K. Maciejewski, J.P. (2007) SNP-A based karyotyping facilitates improved mapping of deletions and uniparental disomy within the long arm of chromosome 5 in myeloid disorders. Blood (ASH Annual Meeting Abstracts), 110, 2435.
32. Gondek, L.P., Tiu, R., O'Keefe, C.L., Sekeres, M.A., Theil, K.S. Maciejewski, J.P. (2008) Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood, 111, 1534 1542.
33. Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079 2088.
34. Heim, S. Mitelman, F. (1986) Chromosome abnormalities in the myelodysplastic syndromes. Clinics in Haematology, 15, 1003 1021.
35. Hellstrom-Lindberg, E. (1995) Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. British Journal Haematology, 89, 67 71.
36. Hellstrom-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I.M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Nilsson-Ehle, H., Samuelsson, J., Tangen, J.M., Winqvist, I., Oberg, G., Osterborg, A. Ost, A. (1998) Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood, 92, 68 75.
37. Hellstrom-Lindberg, E., Gulbrandsen, N., Lindberg, G., Ahlgren, T., Dahl, I.M., Dybedal, I., Grimfors, G., Hesse-Sundin, E., Hjorth, M., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Oberg, G., Porwit-MacDonald, A., Radlund, A., Samuelsson, J., Tangen, J.M., Winquist, I. Wisloff, F. (2003) A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life. British Journal Haematology, 120, 1037 1046.
38. Herry, A., Douet-Guilbert, N., Morel, F., Le Bris, M.J., Morice, P., Abgrall, J.F., Berthou, C. De Braekeleer, M. (2007) Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions. Cancer Genetics and Cytogenetics, 175, 125 131.
39. Hill, E., Clarke, M. Barr, F.A. (2000) The Rab6-binding kinesin, Rab6-KIFL, is required for cytokinesis. EMBO Journal, 19, 5711 5719.
40. Hirokawa, N., Noda, Y. Okada, Y. (1998) Kinesin and dynein superfamily proteins in organelle transport and cell division. Current Opinion in Cell Biology, 10, 60 73.
41. Idol, R.A., Robledo, S., Du, H.Y., Crimmins, D.L., Wilson, D.B., Ladenson, J.H., Bessler, M. Mason, P.J. (2007) Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells, Molecules, and Diseases, 39, 35 43.
42. Jaffe, E.S., Harris, N.L., Stein, H. Vardiman, J.W. (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France.
43. Jaju, R.J., Boultwood, J., Oliver, F.J., Kostrzewa, M., Fidler, C., Parker, N., McPherson, J.D., Morris, S.W., Muller, U., Wainscoat, J.S. Kearney, L. (1998) Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome. Genes, Chromosomes and Cancer, 22, 251 256.
44. Jakovljevic, J., de Mayolo, P.A., Miles, T.D., Nguyen, T.M., Leger-Silvestre, I., Gas, N. Woolford, Jr., J.L. (2004) The carboxy-terminal extension of yeast ribosomal protein S14 is necessary for maturation of 43S preribosomes. Molecular Cell, 14, 331 342.
45. Kelaidi, C., Eclache, V. Fenaux, P. (2008) The role of lenalidomide in the management of myelodysplasia with del 5q. British Journal Haematology, 140, 267 278.
46. Le Beau, M.M., Espinosa, III., R., Neuman, W.L., Stock, W., Roulston, D., Larson, R.A., Keinanen, M. Westbrook, C.A. (1993) Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proceedings of the National Academy of Sciences of the United States of America, 90, 5484 5488.
47. Lea, N.C., Mohamedali, A., Twine, N., Gaken, J., Westwood, N., Ingram, W. Mufti, G. (2006) Kinesin family member 20A (KIF20A) is specifically down regulated in 5q- CD34+ and CD61+ cells and uniparental disomy is not a feature of 5q- syndrome. Blood (ASH Annual Meeting Abstracts), 108, 2611.
48. Lehmann, S., O'Kelly, J., Raynaud, S., Funk, S.E., Sage, E.H. Koeffler, H.P. (2007) Common deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice. Leukemia, 21, 1931 1936.
49. Lessard, M., Helias, C., Struski, S., Perrusson, N., Uettwiller, F., Mozziconacci, M.J., Lafage-Pochitaloff, M., Dastugue, N., Terre, C., Brizard, F., Cornillet-Lefebvre, P., Mugneret, F., Barin, C., Herry, A., Luquet, I., Desangles, F., Michaux, L., Verellen-Dumoulin, C., Perrot, C., Van den Akker, J., Lespinasse, J., Eclache, V. Berger, R. (2007) Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ? Cancer Genetics and Cytogenetics, 176, 1 21.
50. Lew, D.J. Kornbluth, S. (1996) Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Current Opinion in Cell Biology, 8, 795 804.
51. List, A., Kurtin, S., Roe, D.J., Buresh, A., Mahadevan, D., Fuchs, D., Rimsza, L., Heaton, R., Knight, R. Zeldis, J.B. (2005) Efficacy of lenalidomide in myelodysplastic syndromes. New England Journal of Medicine, 352, 549 557.
52. List, A., Dewald, G., Bennett, J., Giagounidis, A., Raza, A., Feldman, E., Powell, B., Greenberg, P., Thomas, D., Stone, R., Reeder, C., Wride, K., Patin, J., Schmidt, M., Zeldis, J. Knight, R. (2006) Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. New England Journal of Medicine, 355, 1456 1465.
53. Liu, J.M. Ellis, S.R. (2006) Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood, 107, 4583 4588.
54. Liu, T.X., Becker, M.W., Jelinek, J., Wu, W.S., Deng, M., Mikhalkevich, N., Hsu, K., Bloomfield, C.D., Stone, R.M., DeAngelo, D.J., Galinsky, I.A., Issa, J.P., Clarke, M.F. Look, A.T. (2007) Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. Nature Medicine, 13, 78 83.
55. Lodish, H.F. Darnell, J.E. (1995) Molecular Cell Biology. Scientific American Books: Distributed by W.H. Freeman and Co., New York.
56. Lodish, H.F. Nathan, D.G. (1972) Regulation of hemoglobin synthesis. Preferential inhibition of and globin synthesis. Journal of Biological Chemistry, 247, 7822 7829.
57. Mannone, L., Gardin, C., Quarre, M.C., Bernard, J.F., Vassilieff, D., Ades, L., Park, S., Vaultier, S., Hamza, F., Beyne-rauzy, M.O., Cheze, S., Giraudier, S., Agape, P., Legros, L., Voillat, L., Dreyfus, F. Fenaux, P. (2006) High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study. British Journal Haematology, 133, 513 519.
58. Margolis, S.S., Perry, J.A., Forester, C.M., Nutt, L.K., Guo, Y., Jardim, M.J., Thomenius, M.J., Freel, C.D., Darbandi, R., Ahn, J.H., Arroyo, J.D., Wang, X.F., Shenolikar, S., Nairn, A.C., Dunphy, W.G., Hahn, W.C., Virshup, D.M. Kornbluth, S. (2006a) Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell, 127, 759 773.
59. Margolis, S.S., Perry, J.A., Weitzel, D.H., Freel, C.D., Yoshida, M., Haystead, T.A. Kornbluth, S. (2006b) A role for PP1 in the Cdc2/Cyclin B-mediated positive feedback activation of Cdc25. Molecular Biology of the Cell, 17, 1779 1789.
60. Martin-Nieto, J. Roufa, D.J. (1997) Functional analysis of human RPS14 null alleles. Journal of Cell Science, 110 Pt 8 955 963.
61. Mathew, P., Tefferi, A., Dewald, G.W., Goldberg, S.L., Su, J., Hoagland, H.C. Noel, P. (1993) The 5q- syndrome: a single-institution study of 43 consecutive patients. Blood, 81, 1040 1045.
62. Mauro, V.P. Edelman, G.M. (2007) The ribosome filter redux. Cell Cycle, 6, 2246 2251.
63. Mazumder, B., Sampath, P., Seshadri, V., Maitra, R.K., DiCorleto, P.E. Fox, P.L. (2003) Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control. Cell, 115, 187 198.
64. Merchant, S.H., Gonchoroff, N.J. Hutchison, R.E. (2001) Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes. Cytometry, 46, 28 32.
65. Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T. Taniguchi, T. (1988) Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell, 54, 903 913.
66. Mohamedali, A., Gaken, J., Twine, N.A., Ingram, W., Westwood, N., Lea, N.C., Hayden, J., Donaldson, N., Aul, C., Gattermann, N., Giagounidis, A., Germing, U., List, A.F. Mufti, G.J. (2007) Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. Blood, 110, 3365 3373.
67. Moritz, M., Paulovich, A.G., Tsay, Y.F. Woolford, Jr., J.L. (1990) Depletion of yeast ribosomal proteins L16 or rp59 disrupts ribosome assembly. Journal of Cell Biology, 111, 2261 2274.
68. Nerlov, C. (2004) C/EBPalpha mutations in acute myeloid leukaemias. Nature Reviews. Cancer, 4, 394 400.
69. Nilsson, L., Eden, P., Olsson, E., Mansson, R., Astrand-Grundstrom, I., Strombeck, B., Theilgaard-Monch, K., Anderson, K., Hast, R., Hellstrom-Lindberg, E., Samuelsson, J., Bergh, G., Nerlov, C., Johansson, B., Sigvardsson, M., Borg, A. Jacobsen, S.E. (2007) The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes. Blood, 110, 3005 3014.
70. Nissen, P., Hansen, J., Ban, N., Moore, P.B. Steitz, T.A. (2000) The structural basis of ribosome activity in peptide bond synthesis. Science, 289, 920 930.
71. Nygard, O. Nika, H. (1982) Identification by RNA-protein cross-linking of ribosomal proteins located at the interface between the small and the large subunits of mammalian ribosomes. EMBO Journal, 1, 357 362.
72. Ong, H.C. Palmer, J.D. (2006) Pervasive survival of expressed mitochondrial rps14 pseudogenes in grasses and their relatives for 80 million years following three functional transfers to the nucleus. BMC Evolutionary Biology, 6, 55.
73. Overman, P.F., Rhoads, D.D., Tasheva, E.S., Pyle, M.M. Roufa, D.J. (1993) Multiple regulatory elements ensure accurate transcription of a human ribosomal protein gene. Somatic Cell and Molecular Genetics, 19, 347 362.
74. Park, S., Grabar, S., Kelaidi, C., Beyne-Rauzy, O., Picard, F., Bardet, V., Coiteux, V., Leroux, G., Lepelley, P., Daniel, M.T., Cheze, S., Mahe, B., Ferrant, A., Ravoet, C., Escoffre-Barbe, M., Ades, L., Vey, N., Aljassem, L., Stamatoullas, A., Mannone, L., Dombret, H., Bourgeois, K., Greenberg, P., Fenaux, P. Dreyfus, F. (2008) Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience. Blood, 111, 574 582.
75. Paulovich, A.G., Thompson, J.R., Larkin, J.C., Li, Z. Woolford, Jr., J.L. (1993) Molecular genetics of cryptopleurine resistance in Saccharomyces cerevisiae: expression of a ribosomal protein gene family. Genetics, 135, 719 730.
76. Pellagatti, A., Cazzola, M., Giagounidis, A.A., Malcovati, L., Porta, M.G., Killick, S., Campbell, L.J., Wang, L., Langford, C.F., Fidler, C., Oscier, D., Aul, C., Wainscoat, J.S. Boultwood, J. (2006) Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Blood, 108, 337 345.
77. Pellagatti, A., Jadersten, M., Forsblom, A.M., Cattan, H., Christensson, B., Emanuelsson, E.K., Merup, M., Nilsson, L., Samuelsson, J., Sander, B., Wainscoat, J.S., Boultwood, J. Hellstrom-Lindberg, E. (2007) Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients. Proceedings of the National Academy of Sciences of the United States of America, 104, 11406 11411.
78. Pellagatti, A., Hellstrom-Lindberg, E., Giagounidis, A., Perry, J., Malcovati, L., Della Porta, M.G., Jadersten, M., Killick, S., Fidler, C., Cazzola, M., Wainscoat, J.S. Boultwood, J. (2008) Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes. British Journal Haematology, 142, 57 64.
79. Perry, R.P. (2007) Balanced production of ribosomal proteins. Gene, 401, 1 3.
80. Raza, A., Alvi, S., Borok, R.Z., Span, L., Parcharidou, A., Alston, D., Rifkin, S., Robin, E., Shah, R. Gregory, S.A. (1997) Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: the cause-effect relationship. Leukaemia & Lymphoma, 27, 111 118.
81. Raza, A., Reeves, J.A., Feldman, E.J., Dewald, G.W., Bennett, J.M., Deeg, H.J., Dreisbach, L., Schiffer, C.A., Stone, R.M., Greenberg, P.L., Curtin, P.T., Klimek, V.M., Shammo, J.M., Thomas, D., Knight, R.D., Schmidt, M., Wride, K., Zeldis, J.B. List, A.F. (2008) Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q. Blood, 111, 86 93.
82. Rhoads, D.D., Dixit, A. Roufa, D.J. (1986) Primary structure of human ribosomal protein S14 and the gene that encodes it. Molecular and Cellular Biology, 6, 2774 2783.
83. Shimamura, A. (2006) Inherited bone marrow failure syndromes: molecular features. Hematology (American Society of Hematology Education Program), 2006, 63 71.
84. Sokal, G., Michaux, J.L., Van Den Berghe, H., Cordier, A., Rodhain, J., Ferrant, A., Moriau, M., De Bruyere, M. Sonnet, J. (1975) A new hematologic syndrome with a distinct karyotype: the 5q- chromosome. Blood, 46, 519 533.
85. Sole, F., Espinet, B., Sanz, G.F., Cervera, J., Calasanz, M.J., Luno, E., Prieto, F., Granada, I., Hernandez, J.M., Cigudosa, J.C., Diez, J.L., Bureo, E., Marques, M.L., Arranz, E., Rios, R., Martinez Climent, J.A., Vallespi, T., Florensa, L. Woessner, S. (2000) Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. British Journal Haematology, 108, 346 356.
86. Takagi, M., Absalon, M.J., McLure, K.G. Kastan, M.B. (2005) Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell, 123, 49 63.
87. Taniuchi, K., Nakagawa, H., Nakamura, T., Eguchi, H., Ohigashi, H., Ishikawa, O., Katagiri, T. Nakamura, Y. (2005) Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell. Cancer Research, 65, 105 112.
88. Tasheva, E.S. Roufa, D.J. (1995a) Regulation of human RPS14 transcription by intronic antisense RNAs and ribosomal protein S14. Genes and Development, 9, 304 316.
89. Tasheva, E.S. Roufa, D.J. (1995b) A densely methylated DNA island is associated with a chromosomal replication origin in the human RPS14 locus. Somatic Cell and Molecular Genetics, 21, 369 383.
90. Tasheva, E.S., Ariyasu, T., Matsuo, Y., Drexler, H.G. Minowada, J. (1993) Possible new genetic marker for human lymphoid leukemias as detected by ribosomal protein S14 cDNA. Leukemia, 7, 318 322.
91. Terpos, E., Mougiou, A., Kouraklis, A., Chatzivassili, A., Michalis, E., Giannakoulas, N., Manioudaki, E., Lazaridou, A., Bakaloudi, V., Protopappa, M., Liapi, D., Grouzi, E., Parharidou, A., Symeonidis, A., Kokkini, G., Laoutaris, N.P., Vaipoulos, G., Anagnostopoulos, N.I., Christakis, J.I., Meletis, J., Bourantas, K.L., Zoumbos, N.C., Yataganas, X. Viniou, N.A. (2002) Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients. British Journal Haematology, 118, 174 180.
92. Thomas, N.S.B. (2005) Cell cycle regulation. In : Textbook of Malignant Hematology (eds by L. Degos, D.C. Linch B. Lowenberg pp. 876. Taylor & Francis, London.
93. Van den Berghe, H., Cassiman, J.J., David, G., Fryns, J.P., Michaux, J.L. Sokal, G. (1974) Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature, 251, 437 438.
94. Van den Berghe, H., Vermaelen, K., Mecucci, C., Barbieri, D. Tricot, G. (1985) The 5q-anomaly. Cancer Genetics and Cytogenetics, 17, 189 255.
95. Wang, L., Fidler, C., Nadig, N., Giagounidis, A., Della Porta, M.G., Malcovati, L., Killick, S., Gattermann, N., Aul, C., Boultwood, J. Wainscoat, J.S. (2008) Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays. Haematologica, 93, 994 1000.
96. Warner, J.R., Kumar, A., Udem, S.A. Wu, R.S. (1973) Ribosomal proteins and the assembly of ribosomes in eukaryotes. Biochemical Society Symposia, 37, 3 22.
97. Wei, S., Rocha, K., Williams, A., Chen, X., Burnette, P.K., Djeu, J.Y., Liu, Q., Byrd, J., Sokol, L., Lawrence, N., Pireddu, R., Dewald, G., Maciejewski, J. List, A. (2007) Gene dosage of the cell cycle regulatory phosphatases Cdc25C and PP2A determines sensitivity to lenalidomide in del(5q) MDS. ASH Annual Meeting Abstracts, 110, 118.
98. Willman, C.L., Sever, C.E., Pallavicini, M.G., Harada, H., Tanaka, N., Slovak, M.L., Yamamoto, H., Harada, K., Meeker, T.C., List, A.F. Taniguchi, T. (1993) Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science, 259, 968 971.
99. Zhao, N., Stoffel, A., Wang, P.W., Eisenbart, J.D., Espinosa, III., R., Larson, R.A. Le Beau, M.M. (1997) Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proceedings of the National Academy of Sciences of the United States of America, 94, 6948 6953.